Company record
Agile Sciences, Inc. develops and manufactures amino‑imidazole compounds, offering both small‑molecule agents and biopharmaceutical products. Its portfolio targets multidrug‑resistant bacterial infections, chronic wound infections, and lung infections associated with cystic fibrosis.
This directory record does not yet have a linked material-flow brief.